Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
PPL Corp
PPL
|
$287M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
$183M |
| 3 |
Biogen
BIIB
|
$178M |
| 4 |
Bank of New York Mellon
BK
|
$151M |
| 5 |
MON
Monsanto Co
MON
|
$150M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$395M |
| 2 |
Pfizer
PFE
|
$277M |
| 3 |
Valero Energy
VLO
|
$198M |
| 4 |
Devon Energy
DVN
|
$179M |
| 5 |
Altria Group
MO
|
$168M |
Sector Composition
| 1 | Healthcare | 15.39% |
| 2 | Energy | 12.34% |
| 3 | Financials | 9.62% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
East-West Bancorp
EWBC
$14.8B
| $42.6M | 0.08% |
+949,952
| New | +$42.6M |
|
302
TIM SA
TIMB
$10.3B
| $42.5M | 0.08% |
2,599,453
+1,191,417
| +85% | +$19.5M |
|
303
Darling Ingredients
DAR
$5.07B
| $42.5M | 0.08% |
2,900,688
+2,643,270
| +1,027% | +$38.8M |
|
|
UCB
304
United Community Banks, Inc.
UCB
$4.04B
| $42.3M | 0.08% |
2,025,760
+262,400
| +15% | +$5.48M |
|
305
Intuitive Surgical
ISRG
$167B
| $42.2M | 0.08% |
784,161
-956,817
| -55% | -$51.5M |
|
|
JNS
306
DELISTED
Janus Capital Group Inc
JNS
| $41.9M | 0.08% |
2,446,450
+1,347,334
| +123% | +$23.1M |
|
307
Regency Centers
REG
$13.4B
| $41.7M | 0.08% |
706,170
+353,881
| +100% | +$20.9M |
|
308
Cooper Companies
COO
$13.5B
| $41.6M | 0.08% |
933,964
+149,892
| +19% | +$6.67M |
|
309
Merck
MRK
$212B
| $41.5M | 0.08% |
763,961
-654,342
| -46% | -$35.5M |
|
310
Technology Select Sector SPDR Fund
XLK
$84.1B
| $41.4M | 0.08% |
999,453
+555,981
| +125% | +$23M |
|
311
NetEase
NTES
$85B
| $41.3M | 0.08% |
1,424,610
+1,315,605
| +1,207% | +$38.1M |
|
312
Chevron
CVX
$310B
| $41M | 0.08% |
424,520
+394,669
| +1,322% | +$38.1M |
|
313
Gen Digital
GEN
$18.2B
| $40.7M | 0.08% |
1,751,644
-468,336
| -21% | -$10.9M |
|
314
Analog Devices
ADI
$122B
| $40.6M | 0.08% |
632,342
+415,333
| +191% | +$26.7M |
|
|
LGF
315
DELISTED
Lions Gate Entertainment
LGF
| $40.6M | 0.08% |
1,094,970
+417,616
| +62% | +$15.5M |
|
316
Lennar Class A
LEN
$36.7B
| $40.4M | 0.08% |
+832,523
| New | +$40.4M |
|
317
Baidu
BIDU
$35.1B
| $40.4M | 0.08% |
203,155
-67,149
| -25% | -$13.4M |
|
|
SE
318
DELISTED
Spectra Energy Corp Wi
SE
| $40.3M | 0.08% |
+1,234,864
| New | +$40.3M |
|
|
ATHN
319
DELISTED
Athenahealth, Inc.
ATHN
| $40.2M | 0.08% |
351,238
+121,272
| +53% | +$13.9M |
|
320
Evercore
EVR
$12.3B
| $40.2M | 0.08% |
744,093
-151,927
| -17% | -$8.2M |
|
321
Alibaba
BABA
$323B
| $40.1M | 0.08% |
487,477
+392,533
| +413% | +$32.3M |
|
|
PDCO
322
DELISTED
Patterson Companies, Inc.
PDCO
| $40.1M | 0.08% |
824,361
+775,362
| +1,582% | +$37.7M |
|
323
GE Aerospace
GE
$296B
| $40.1M | 0.08% |
+314,869
| New | +$40.1M |
|
324
Bio-Rad Laboratories Class A
BIO
$8B
| $40.1M | 0.08% |
266,121
-31,803
| -11% | -$4.79M |
|
325
DexCom
DXCM
$31.6B
| $39.9M | 0.08% |
1,994,488
-1,476,176
| -43% | -$29.5M |
|